Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2013
11/19/2013US8586358 HLA homozygous cells
11/19/2013US8586357 Markers of definitive endoderm
11/19/2013US8586356 Gal α1-3gal-containing N-glycans in glycoprotein products derived from CHO cells
11/19/2013US8586345 Electroprocessed collagen and tissue engineering
11/19/2013US8586341 Method and devices for non-traumatic movement of a probe through biological cell material
11/19/2013US8586317 Methods of diagnosing hypophosphatemic disorders
11/19/2013US8586100 Populations of hematopoietic stem cells
11/19/2013US8586086 Hydrogel capable of containing and conveying cells
11/19/2013CA2713626C Method to improve germination of embryos from manufactured seed
11/19/2013CA2604608C Antibody directed against gastrin-releasing peptide precursor and use thereof
11/19/2013CA2447139C Specific binding proteins and uses thereof
11/19/2013CA2442684C Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
11/19/2013CA2434845C Hepatitis c virus replicons and replicon enhanced cells
11/19/2013CA2411694C Furin polypeptides with improved characteristics
11/19/2013CA2404890C Rna sequence-specific mediators of rna interference
11/19/2013CA2398083C Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
11/19/2013CA2383217C Lysosomal targeting pathway enzymes
11/19/2013CA2346996C Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
11/19/2013CA2290220C An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
11/14/2013WO2013170152A2 Human persistent fetal vasculature neural progenitors for transplantation in the inner retina
11/14/2013WO2013169922A1 Standardized ex vivo platforms for the antigen-specific expansion of cd4+ t cell populations
11/14/2013WO2013169802A1 Methods and compositions for nuclease-mediated targeted integration of transgenes
11/14/2013WO2013169769A1 Differentiation of human embryonic stem cells into pancreatic endoderm
11/14/2013WO2013169386A1 Methods and compositions for infusion of transiently engrafting, selected populations of allogeneic lymphocytes to treat cancer
11/14/2013WO2013169202A1 Osteogenic differentiation of mesenchymal stem cells
11/14/2013WO2013168978A1 Method for inducing and proliferating natural killer cells derived from peripheral blood mononuclear cells
11/14/2013WO2013168807A1 Additive for graft cell suspension, and therapeutic composition
11/14/2013WO2013168438A1 Protein having lactase activity, gene encoding said protein, recombinant vector carrying said gene, transformant, method for producing said protein, and use of said protein
11/14/2013WO2013168403A1 Trehalose-containing mammalian cell suspension for prevention of pulmonary embolism formation
11/14/2013WO2013168402A1 Dextran-containing mammalian cell suspension for prevention of pulmonary embolism formation
11/14/2013WO2013168310A1 Method for producing oxo fatty acid and rare fatty acid
11/14/2013WO2013167471A1 Artificial forisome body with seo-f fusion proteins, plant or yeast cells comprising vectors which code for these proteins, as well as vectors which code for seo-f fusion proteins
11/14/2013WO2013167265A1 Nucleic acid construct and use of the same
11/14/2013WO2013166604A1 Single-arm monovalent antibody constructs and uses thereof
11/14/2013WO2013141731A3 Process for ex-vivo expansion of hematopoietic stem cells in a bioreactor
11/14/2013WO2012106669A3 Foxc1 antibodies and methods of their use
11/14/2013WO2003006605A9 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/14/2013US20130305400 Capulin lettuce variety
11/14/2013US20130303573 Brown Adipocyte Progenitors in Human Skeletal Muscle
11/14/2013US20130302897 Deformable transportable bioreactor chamber
11/14/2013US20130302896 Soy-protein containing porous materials
11/14/2013US20130302893 Method for increasing the efficiency of inducing pluripotent stem cells
11/14/2013US20130302892 Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
11/14/2013US20130302891 Compositions and methods for promoting liposomal and cellular adhesion
11/14/2013US20130302890 Stem cells & matrix from cord tissue
11/14/2013US20130302889 Differentiation of Bone Marrow Cells into Neuronal Cells and Uses Therefor
11/14/2013US20130302888 Cell culture method and system for establishing an in vitro model of the intestinal barrier
11/14/2013US20130302887 Compositions and methods for growing human embryonic cells
11/14/2013US20130302885 Method of Forming Cell Spheroids Cultured in Serum-Free Manner on Nanoscale Coatings of Hyaluronic Acid with High Molecular Weight
11/14/2013US20130302846 Pluripotent cells from mammalian late epiblast layer
11/14/2013US20130302780 Method of blood pooling and storage
11/14/2013US20130302426 Modalities for the treatment of degenerative diseases of the retina
11/14/2013US20130302340 Human timp-1 antibodies
11/14/2013US20130302302 Dendritic cells having enhanced yo t-cell activating and/or proliferating activity and methods of preparation or use thereof
11/14/2013US20130302301 Antibody and methods for selective inhibition of t-cell responses
11/14/2013US20130302300 B and t lymphocyte attenuator marker for use in adoptive t-cell therapy
11/14/2013US20130302295 Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna
11/14/2013US20130302289 Methods for Modulating Immune Responses
11/14/2013US20130302288 Modalities for the treatment of degenerative diseases of the retina
11/14/2013US20130302286 Modalities for the treatment of degenerative diseases of the retina
11/14/2013US20130302285 Wharton's Jelly Mesenchymal Stem Cells and Uses Thereof
11/14/2013US20130302273 Compositions derived from stem cell released molecules & methods for formulation thereof
11/13/2013EP2662451A1 Nucleic acid construct and use of the same
11/13/2013EP2662448A1 Bone targeted alkaline phosphatase, kits and methods of use thereof
11/13/2013EP2662447A1 Artificial forisome bodies with SEO-F fusion protein, plant or yeast cells with vectors for encoding these proteins and vectors for encoding SEO-F fusion proteins
11/13/2013EP2662445A2 Method for designing mutated enzyme, method for preparing the same and mutated enzyme
11/13/2013EP2662441A1 Method for the in vitro maturation of dendritic cells
11/13/2013EP2662440A1 Isolated renal cells and uses thereof
11/13/2013EP2662439A1 Treatment of ischemia using stem cells
11/13/2013EP2662387A1 Antibody to signal peptide of amyloid precursor protein
11/13/2013EP2662085A1 Regulatory Macrophages and Their Uses
11/13/2013EP2661623A2 In vitro urogenital co-culture models
11/13/2013EP2661492A2 Method of production of recombinant glycoproteins with increased circulatory half-life in mammalian cells
11/13/2013EP2661491A1 Personalized production of biologics and method for reprogramming somatic cells
11/13/2013EP2661490A1 Tumour cell and tissue culture
11/13/2013EP2661489A2 Methods for enhancing the delivery of gene-transduced cells
11/13/2013EP2661488A1 Method and system for suspension cell culture
11/13/2013EP2374894A9 A method for producing influenza hemagglutinin multivalent vaccines
11/13/2013CN103391998A Vectors and methods for recombinant protein expression
11/13/2013CN103388008A Ungulate animal cell line for inductively expressing pluripotent maintenance gene and construction thereof
11/13/2013CN103388007A Method for preparing tissue engineering spinal cords by using mesenchymal stem cells derived from dermis
11/13/2013CN103388006A Method for constructing gene site-directed mutation
11/13/2013CN103388001A A thrombin cleavage site-containing GST membrane expression vector and a method for sorting transfected positive cells
11/13/2013CN103387986A Abiotic-stress induction type ultrastrong promoter in rice and application thereof
11/13/2013CN103387963A Ming classification human expansive type gastric cancer cell line and application thereof
11/13/2013CN103387962A Autologous stem cell anti-aging technology with efficacy of resisting aging and prolonging life
11/13/2013CN103387961A CD3<+>CD56<+>T cell for FOXP3 expression and application thereof
11/13/2013CN103387960A mTOR signaling pathway activator and applications thereof in in-vitro primordial follicle activation
11/13/2013CN103387959A Stem cell from deciduous teeth, and preparation method and application thereof
11/13/2013CN103387958A Human embryonic lung fibroblastic cell SV-7 and application thereof
11/13/2013CN103387957A Human embryonic lung fibroblastic cell SV-4 and application thereof
11/13/2013CN103387956A Method and device for acute isolation of myocardial cells
11/13/2013CN103387955A Making method and use of non-human mammal B lymphocyte defect animal model
11/13/2013CN103387954A Culture medium and kit for preparing embryonic callus of cotton and applications of culture medium and kit
11/13/2013CN103387953A Application of water-soluble carbon nano-grade material
11/13/2013CN103387952A New application of gamma-secretase inhibitor and method for improving susceptibility of eukaryotic cells to coxsackie virus B (CVB)
11/13/2013CN103387946A Preparation method for competent host cell, and method for rapid and highly efficient transfer of exogenous substances into host cell and application thereof
11/13/2013CN103387621A Method for producing beautiful millettia root polysaccharides from non-embryonic cells of millettia dielsiana through suspension cultivation
11/13/2013CN103387617A Targeted recombinant PF4 (platelet factor 4) and expression system thereof
11/13/2013CN103387616A Erythropoietin (EPO) variant-Fc fusion protein
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 1827